Yahoo
Stockholm - Delayed Quote SEK

Nolato AB (publ) (NOLA-B.ST)

52.10 -1.60 (-2.98%)
At close: October 30 at 12:59:54 PM GMT+1
NOLA-B.ST Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for NOLA-B.ST
  • Previous Close 53.70
  • Open 53.00
  • Bid 51.80 x --
  • Ask 51.90 x --
  • Day's Range 51.80 - 53.00
  • 52 Week Range 44.80 - 64.10
  • Volume 115,160
  • Avg. Volume 216,822
  • Market Cap (intraday) 14.035B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 20.84
  • EPS (TTM) 2.50
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 1.70 (3.17%)
  • Ex-Dividend Date May 7, 2026
  • 1y Target Est 66.00

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; Autolys M products, deep well plates, microtubes, PCR/qPCR products, pipettes and slim-line pipette tips, vial HP, and quality grades under the TreffLab by Nolato; and electromagnetic compatibility (EMC) products, including Compashield molded and extruded electromagnetic interference (EMI) shielding gaskets, Trishield, and MIL SPEC EMI shielding products. In addition, the company offers laboratory products, such as boxes with integrated lids; containers with hinged lids; sampling and transport tubes; spoons and cups; disposable tubes and containers; test tubes and ergonomic caps; and containers, vials, and slide tubes with push on lids. Further, it provides injection molding of plastic and silicone, injection blow molding, scientific and ceramic injection molding, dip and compression molding, and micro molding; extrusion and silicone sponge extrusion technologies; thermal management; decoration and cutting technologies; cleanroom production; assembly solutions; design and virtual prototyping solutions; and tool manufacturing. It serves medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.

www.nolato.com

5,343

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

NOLA-B.ST
12.75%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

NOLA-B.ST
15.42%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

NOLA-B.ST
16.32%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

NOLA-B.ST
46.50%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 2.5B
Earnings 172M
Profit Margin 6.88%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

0
500M
1B
2B
2B
3B
7.0%
7.5%
8.0%
8.5%
9.0%

Analyst Insights

View More

Analyst Price Targets

63.00
66.00 Average
52.10 Current
69.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.02%

  • Return on Assets (ttm)

    5.84%

  • Return on Equity (ttm)

    11.77%

  • Revenue (ttm)

    9.58B

  • Net Income Avi to Common (ttm)

    673M

  • Diluted EPS (ttm)

    2.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    584M

  • Total Debt/Equity (mrq)

    25.61%

  • Levered Free Cash Flow (ttm)

    1.07B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: